A couple of Texas Supreme Court developments of interest. (1) the court reversed the adverse Vioxx decision in Garza - holding that the plaintiffs did not provide sufficient epidemiological evidence in a low dose case. A copy of the opinion, which requires two epidemiological studies showing a relative risk of 2 or more, is available here (Please see below.)
Please see full publication below for more information.
